Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

@article{Nicholls2011EffectsOT,
  title={Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.},
  author={Stephen J Nicholls and Hollis B Brewer and John J. P. Kastelein and Kathryn A. Krueger and Ming-Dauh Wang and Mingyuan Shao and Bo Hu and Ellen S McErlean and Steven Evan Nissen},
  journal={JAMA},
  year={2011},
  volume={306 19},
  pages={2099-109}
}
CONTEXT Interest remains high in cholesteryl ester transfer protein (CETP) inhibitors as cardioprotective agents. Few studies have documented the efficacy and safety of CETP inhibitors in combination with commonly used statins. OBJECTIVE To examine the biochemical effects, safety, and tolerability of evacetrapib, as monotherapy and in combination with statins, in patients with dyslipidemia. DESIGN, SETTING, AND PARTICIPANTS Randomized controlled trial conducted among 398 patients with… CONTINUE READING
129 Citations
35 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 129 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Associa - tion of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community

  • A Ritsch, H Scharnagl, P Eller
  • Circulation
  • 2009

Similar Papers

Loading similar papers…